Report Detail
Global Amniotic Tissue Allografts Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4687033 |
- 27 April, 2026 |
- Global |
- 122 Pages |
- GIR |
- Medical Devices & Consumables
According to our (Global Info Research) latest study, the global Amniotic Tissue Allografts market size was valued at US$ 587 million in 2025 and is forecast to a readjusted size of US$ 837 million by 2032 with a CAGR of 5.3% during review period.
Amniotic tissue allografts are biomedical products derived from donated amniotic tissues, which are collected during the delivery of a baby by a consenting mother. Amniotic tissue allografts undergo extensive processing to create a graft or patch that can be used in various medical procedures. These allografts contain a variety of beneficial factors, such as growth factors, cytokines, and extracellular matrix proteins, which contribute to tissue regeneration and wound healing. They are commonly used in surgical applications, such as treating chronic wounds, promoting tissue repair, and reducing inflammation.
Amniotic tissue allografts represent a promising regenerative medicine solution, with growth driven by increasing clinical adoption in wound care, ophthalmology, and orthopedics. The industry's development hinges on achieving standardized processing methods while expanding evidence-based applications beyond current niche uses. Regulatory clarity and physician education remain critical challenges that will determine whether these biologically active scaffolds transition from specialty use to mainstream therapeutic options.
Key factors influencing market evolution include: (1) technological advancements in tissue preservation and processing that maintain biological potency, (2) clinical validation for expanded indications beyond current wound healing applications, and (3) reimbursement policies that recognize their therapeutic value relative to conventional treatments. The sector must balance innovation with rigorous quality control as products move toward broader commercialization.
This report is a detailed and comprehensive analysis for global Amniotic Tissue Allografts market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Amniotic Tissue Allografts market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Amniotic Tissue Allografts market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Amniotic Tissue Allografts market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Amniotic Tissue Allografts market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Amniotic Tissue Allografts
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Amniotic Tissue Allografts market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include VIVEX, Alamo Biologics, BioTissue, Integra LifeSciences, Legacy Medical Consultants, LifeCell, MIMEDX, Samaritan Biologics, Skye Biologics, Stability Biologics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Amniotic Tissue Allografts market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Single Layer Amniotic Tissue Allografts
Double Layer Amniotic Tissue Allografts
Others
Market segment by Application
Ophthalmology
Orthopedics
Neurosurgery
Burn Care
Others
Major players covered
VIVEX
Alamo Biologics
BioTissue
Integra LifeSciences
Legacy Medical Consultants
LifeCell
MIMEDX
Samaritan Biologics
Skye Biologics
Stability Biologics
Surgenex
Surgical BioFix
Surgilogix
Tides Medical
Zimmer Biomet
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Amniotic Tissue Allografts product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Amniotic Tissue Allografts, with price, sales quantity, revenue, and global market share of Amniotic Tissue Allografts from 2021 to 2026.
Chapter 3, the Amniotic Tissue Allografts competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Amniotic Tissue Allografts breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Amniotic Tissue Allografts market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Amniotic Tissue Allografts.
Chapter 14 and 15, to describe Amniotic Tissue Allografts sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Amniotic Tissue Allografts Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Single Layer Amniotic Tissue Allografts
- 1.3.3 Double Layer Amniotic Tissue Allografts
- 1.3.4 Others
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Amniotic Tissue Allografts Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Ophthalmology
- 1.4.3 Orthopedics
- 1.4.4 Neurosurgery
- 1.4.5 Burn Care
- 1.4.6 Others
- 1.5 Global Amniotic Tissue Allografts Market Size & Forecast
- 1.5.1 Global Amniotic Tissue Allografts Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Amniotic Tissue Allografts Sales Quantity (2021-2032)
- 1.5.3 Global Amniotic Tissue Allografts Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 VIVEX
- 2.1.1 VIVEX Details
- 2.1.2 VIVEX Major Business
- 2.1.3 VIVEX Amniotic Tissue Allografts Product and Services
- 2.1.4 VIVEX Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 VIVEX Recent Developments/Updates
- 2.2 Alamo Biologics
- 2.2.1 Alamo Biologics Details
- 2.2.2 Alamo Biologics Major Business
- 2.2.3 Alamo Biologics Amniotic Tissue Allografts Product and Services
- 2.2.4 Alamo Biologics Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Alamo Biologics Recent Developments/Updates
- 2.3 BioTissue
- 2.3.1 BioTissue Details
- 2.3.2 BioTissue Major Business
- 2.3.3 BioTissue Amniotic Tissue Allografts Product and Services
- 2.3.4 BioTissue Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 BioTissue Recent Developments/Updates
- 2.4 Integra LifeSciences
- 2.4.1 Integra LifeSciences Details
- 2.4.2 Integra LifeSciences Major Business
- 2.4.3 Integra LifeSciences Amniotic Tissue Allografts Product and Services
- 2.4.4 Integra LifeSciences Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Integra LifeSciences Recent Developments/Updates
- 2.5 Legacy Medical Consultants
- 2.5.1 Legacy Medical Consultants Details
- 2.5.2 Legacy Medical Consultants Major Business
- 2.5.3 Legacy Medical Consultants Amniotic Tissue Allografts Product and Services
- 2.5.4 Legacy Medical Consultants Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Legacy Medical Consultants Recent Developments/Updates
- 2.6 LifeCell
- 2.6.1 LifeCell Details
- 2.6.2 LifeCell Major Business
- 2.6.3 LifeCell Amniotic Tissue Allografts Product and Services
- 2.6.4 LifeCell Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 LifeCell Recent Developments/Updates
- 2.7 MIMEDX
- 2.7.1 MIMEDX Details
- 2.7.2 MIMEDX Major Business
- 2.7.3 MIMEDX Amniotic Tissue Allografts Product and Services
- 2.7.4 MIMEDX Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 MIMEDX Recent Developments/Updates
- 2.8 Samaritan Biologics
- 2.8.1 Samaritan Biologics Details
- 2.8.2 Samaritan Biologics Major Business
- 2.8.3 Samaritan Biologics Amniotic Tissue Allografts Product and Services
- 2.8.4 Samaritan Biologics Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Samaritan Biologics Recent Developments/Updates
- 2.9 Skye Biologics
- 2.9.1 Skye Biologics Details
- 2.9.2 Skye Biologics Major Business
- 2.9.3 Skye Biologics Amniotic Tissue Allografts Product and Services
- 2.9.4 Skye Biologics Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Skye Biologics Recent Developments/Updates
- 2.10 Stability Biologics
- 2.10.1 Stability Biologics Details
- 2.10.2 Stability Biologics Major Business
- 2.10.3 Stability Biologics Amniotic Tissue Allografts Product and Services
- 2.10.4 Stability Biologics Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.10.5 Stability Biologics Recent Developments/Updates
- 2.11 Surgenex
- 2.11.1 Surgenex Details
- 2.11.2 Surgenex Major Business
- 2.11.3 Surgenex Amniotic Tissue Allografts Product and Services
- 2.11.4 Surgenex Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.11.5 Surgenex Recent Developments/Updates
- 2.12 Surgical BioFix
- 2.12.1 Surgical BioFix Details
- 2.12.2 Surgical BioFix Major Business
- 2.12.3 Surgical BioFix Amniotic Tissue Allografts Product and Services
- 2.12.4 Surgical BioFix Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.12.5 Surgical BioFix Recent Developments/Updates
- 2.13 Surgilogix
- 2.13.1 Surgilogix Details
- 2.13.2 Surgilogix Major Business
- 2.13.3 Surgilogix Amniotic Tissue Allografts Product and Services
- 2.13.4 Surgilogix Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.13.5 Surgilogix Recent Developments/Updates
- 2.14 Tides Medical
- 2.14.1 Tides Medical Details
- 2.14.2 Tides Medical Major Business
- 2.14.3 Tides Medical Amniotic Tissue Allografts Product and Services
- 2.14.4 Tides Medical Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.14.5 Tides Medical Recent Developments/Updates
- 2.15 Zimmer Biomet
- 2.15.1 Zimmer Biomet Details
- 2.15.2 Zimmer Biomet Major Business
- 2.15.3 Zimmer Biomet Amniotic Tissue Allografts Product and Services
- 2.15.4 Zimmer Biomet Amniotic Tissue Allografts Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.15.5 Zimmer Biomet Recent Developments/Updates
3 Competitive Environment: Amniotic Tissue Allografts by Manufacturer
- 3.1 Global Amniotic Tissue Allografts Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Amniotic Tissue Allografts Revenue by Manufacturer (2021-2026)
- 3.3 Global Amniotic Tissue Allografts Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Amniotic Tissue Allografts by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Amniotic Tissue Allografts Manufacturer Market Share in 2025
- 3.4.3 Top 6 Amniotic Tissue Allografts Manufacturer Market Share in 2025
- 3.5 Amniotic Tissue Allografts Market: Overall Company Footprint Analysis
- 3.5.1 Amniotic Tissue Allografts Market: Region Footprint
- 3.5.2 Amniotic Tissue Allografts Market: Company Product Type Footprint
- 3.5.3 Amniotic Tissue Allografts Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Amniotic Tissue Allografts Market Size by Region
- 4.1.1 Global Amniotic Tissue Allografts Sales Quantity by Region (2021-2032)
- 4.1.2 Global Amniotic Tissue Allografts Consumption Value by Region (2021-2032)
- 4.1.3 Global Amniotic Tissue Allografts Average Price by Region (2021-2032)
- 4.2 North America Amniotic Tissue Allografts Consumption Value (2021-2032)
- 4.3 Europe Amniotic Tissue Allografts Consumption Value (2021-2032)
- 4.4 Asia-Pacific Amniotic Tissue Allografts Consumption Value (2021-2032)
- 4.5 South America Amniotic Tissue Allografts Consumption Value (2021-2032)
- 4.6 Middle East & Africa Amniotic Tissue Allografts Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Amniotic Tissue Allografts Sales Quantity by Type (2021-2032)
- 5.2 Global Amniotic Tissue Allografts Consumption Value by Type (2021-2032)
- 5.3 Global Amniotic Tissue Allografts Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Amniotic Tissue Allografts Sales Quantity by Application (2021-2032)
- 6.2 Global Amniotic Tissue Allografts Consumption Value by Application (2021-2032)
- 6.3 Global Amniotic Tissue Allografts Average Price by Application (2021-2032)
7 North America
- 7.1 North America Amniotic Tissue Allografts Sales Quantity by Type (2021-2032)
- 7.2 North America Amniotic Tissue Allografts Sales Quantity by Application (2021-2032)
- 7.3 North America Amniotic Tissue Allografts Market Size by Country
- 7.3.1 North America Amniotic Tissue Allografts Sales Quantity by Country (2021-2032)
- 7.3.2 North America Amniotic Tissue Allografts Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Amniotic Tissue Allografts Sales Quantity by Type (2021-2032)
- 8.2 Europe Amniotic Tissue Allografts Sales Quantity by Application (2021-2032)
- 8.3 Europe Amniotic Tissue Allografts Market Size by Country
- 8.3.1 Europe Amniotic Tissue Allografts Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Amniotic Tissue Allografts Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Amniotic Tissue Allografts Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Amniotic Tissue Allografts Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Amniotic Tissue Allografts Market Size by Region
- 9.3.1 Asia-Pacific Amniotic Tissue Allografts Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Amniotic Tissue Allografts Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Amniotic Tissue Allografts Sales Quantity by Type (2021-2032)
- 10.2 South America Amniotic Tissue Allografts Sales Quantity by Application (2021-2032)
- 10.3 South America Amniotic Tissue Allografts Market Size by Country
- 10.3.1 South America Amniotic Tissue Allografts Sales Quantity by Country (2021-2032)
- 10.3.2 South America Amniotic Tissue Allografts Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Amniotic Tissue Allografts Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Amniotic Tissue Allografts Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Amniotic Tissue Allografts Market Size by Country
- 11.3.1 Middle East & Africa Amniotic Tissue Allografts Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Amniotic Tissue Allografts Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Amniotic Tissue Allografts Market Drivers
- 12.2 Amniotic Tissue Allografts Market Restraints
- 12.3 Amniotic Tissue Allografts Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Amniotic Tissue Allografts and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Amniotic Tissue Allografts
- 13.3 Amniotic Tissue Allografts Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Amniotic Tissue Allografts Typical Distributors
- 14.3 Amniotic Tissue Allografts Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Amniotic Tissue Allografts. Industry analysis & Market Report on Amniotic Tissue Allografts is a syndicated market report, published as Global Amniotic Tissue Allografts Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Amniotic Tissue Allografts market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
